Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Learn about the best investment trends for 2023. Make informed decisions to enhance your investment portfolio.
20,868 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Adrian Boafo won Maryland’s crowded MD-05 primary after a $5.5 million infusion from crypto-aligned groups. The victo...
As Anthropic prepares for a public debut, many investors seek exposure to AI beyond private rounds. The AGIX ETF offe...
A tech-focused ETF concentrates 32.8% of its holdings in four giants. Learn what this means for potential gains, risk...
Lucid's stock sits near a critical pricing zone as its balance sheet frays and dilution fears mount, even as producti...
A famous pair built on years of knowing each other offers a lesson in personal finance: long-term trust can simplify ...
Sezzle's CEO argues BNPL market gains are siphoning wallet share from traditional lenders as the fintech reports stro...
A seasoned financial writer explains how a president-defining stance from the new Fed chair can ripple through stocks...
Sandisk leads the 2026 market rally, with outsized gains that eclipse every other S&P 500 stock. Analysts weigh how l...
JPMorgan Chase stands out for its scale, diversified earnings, and capital strength, reinforcing its role as a steady...
A swift rotation out of momentum bets hammered quant trading desks, delivering the year’s sharpest rout for the secto...
Rising sticker prices keep reshaping the auto market, with the ford f-150 expensive price tag drawing renewed scrutin...